Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
Home > products > phospholipids
> lipids-for-drug-delivery
> lyophosome-dotap-based-dotap-dopc-40-60-molar-ratio
Lyophosome-DOTAP-based(DOTAP:DOPC (40:60 molar ratio))
Lyophosome-DOTAP-based(DOTAP:DOPC (40:60 molar ratio))
Product description
Lyophosome-DOTAP-based(DOTAP:DOPC (40:60 molar ratio)),DOTAP is a cationic lipid and the liposomes made from DOTAP are positively charged.The amount of the positive charge depends on the percentage of the DOTAP in the formulation.DOTAP can spontaneously form a lipid bilayer structure,which can effectively encapsulate bioactive substances such as drugs and nucleic acids,protecting them from external environmental influences.
| Appearance | N/A |
|---|---|
| Buffer | Deionized water |
| Lyoprotectant | Trehalose |
| Liposome size | 100 nm (after hydration) |
| Transportation | 4-25℃temperature for up to 3 weeks |
| Storage | -20℃, protected from light and moisture |
| Stability | 1 year |
Document
msds----Lyophosome-DOTAP-based(DOTAP:DOPC (40:60 molar ratio)) Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
